The Bioengineered Protein Drugs Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Bioengineered Protein Drugs Global Market Report 2025 showed a robust growth trend historically. The market size which was $406.39 billion in 2024 is estimated to increase to $439.29 billion in 2025, this indicates a Compound Annual Growth Rate (CAGR) of 8.1%.
The Bioengineered Protein Drugs Global Market Report 2025 predicts the market will expand to $604.42 billion by 2029, with a compound annual growth rate (CAGR) of 8.3%.
Download Your Free Sample of the 2025 Bioengineered Protein Drugs Market Report and Uncover Key Trends Now!The key drivers in the bioengineered protein drugs market are:
• Personalized medicine trends are driving growth in the market
• Expanding therapeutic applications contributes to the market growth
• Emergence of new markets is also a key growth driver
• Increased focus on rare diseases and development of healthcare infrastructure are pushing the market forward.
The bioengineered protein drugs market covered in this report is segmented –
1) By Drug Type: Recombinant Protein, Vaccine, Peptide Antibiotics, Therapeutic Enzymes, Other Drug Type
2) By Technology: Bioreactors, Fractionation, Genetically Modified Organisms, Genetic Engineering, Pharming, Cell Culture, Microbial Cell Fermentation, Other Technology
3) By Application: Autoimmune, Heart, Congenital, Infectious Diseases, Cancer, Diabetes, Arthritis, Other Application
4) By End User: Pharmaceutical, Contract Research Organizations, Research Institutes, Biotechnology Companies
The key trends in the bioengineered protein drugs market are:
• A prominent trend is the advancement in protein engineering techniques.
• There is an escalating focus on monoclonal antibodies in drug development.
• Personalized medicine and targeted therapies are becoming more prevalent in the industry.
• The emergence of next-generation biologics and optimization of manufacturing processes are driving trends.
The major players in the bioengineered protein drugs market are:
• Abbvie Inc
North America was the largest region in the bioengineered protein drugs market in 2024